Application of glucosamine in weight reduction and fat reduction

A kind of glucosamine salt and technology, applied in the field of medicine, can solve the problem of no GLC application, etc., and achieve the effect of superior application effect

Inactive Publication Date: 2014-02-05
GUANGDONG PHARMA UNIV
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] There are currently no reports on the application of GLC to other fields

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of glucosamine in weight reduction and fat reduction
  • Application of glucosamine in weight reduction and fat reduction
  • Application of glucosamine in weight reduction and fat reduction

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] 1 Materials and methods

[0032] 1.1 Test samples

[0033] Glucosamine hydrochloride (GLC·HCl, directly represented by GLC1 in this example, Shandong Laizhou Haili Biological Products Co., Ltd., production batch number HL120930Y), glucosamine sulfate (GLC·H 2 SO 4 , in this example, it is directly represented by GLC2, Shandong Laizhou Haili Biological Products Co., Ltd., production batch number HL120927Y)

[0034] 1.2 Experimental animals

[0035] 140 SPF grade male Sprague Dawley rats (license number: SCXK (Guangdong) 2008-0002), weighing 70-90 g, were purchased from the Guangdong Provincial Medical Laboratory Animal Center and were adaptively fed for one week.

[0036] 1.3 Reagents and Instruments

[0037] Orlistat Capsules (Chongqing Huasen Pharmaceutical Co., Ltd.); Alanine Aminotransferase Assay Kit (ALT), Aspartate Aminotransferase Assay Kit (AST), Triglyceride Assay Kit (TG) , Total Cholesterol Determination Kit (CHO), High Density Lipoprotein Choles...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to the technical field of medicine, particularly to an application of a glucosamine salt. The weight reduction and / or fat reduction drug prepared by adopting the glucosamine salt, especially the drug with effects of weight reduction and fat reduction, provides significant application effects in fields of weight control, appetite ensuring, body fat reduction and liver fat metabolism acceleration. Application research results show that the glucosamine hydrochloride provides more excellent corresponding effects compared with the glucosamine sulfate. The present invention provides the new application of the glucosamine salt, wherein the glucosamine salt has effects of significant weight reduction, significant fat reduction, fatty liver alleviating and serum blood fat reduction.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a new application of glucosamine. Background technique [0002] Obesity is a chronic nutritional disease caused by the imbalance of energy metabolism in the body. Looking around the world, the number of obese people is increasing in every country. 66% of American adults are overweight or obese, and the prevalence of obesity is 32%. In China, as of 2009, the proportion of obesity in men has reached 11.4%, that of women has reached 10.1%, the proportion of abdominal obesity in men is 27.8%, and that of women is 45.9%. Studies have shown that obesity can be caused by multiple factors such as genes, diet, environment, traditions, etc. It is caused by non-alcoholic fatty liver disease (NAFLD), type Ⅱ diabetes, atherosclerosis (AS), tumors, sleep disorders, osteoarthritis, etc. disease predisposing factors. Therefore, finding safe and effective weight-loss drugs has become a resea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7008A61P3/04A61P3/10A61P1/16A61P3/06
Inventor 苏政权陈健黄贵东潘海涛丁晨谭思荣
Owner GUANGDONG PHARMA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products